Blood Transfusion Diagnostics Market
Transfusion Diagnostics Market Forecast to 2028 - COVID-19 Impact and Global Analysis By Product (Instruments & Kits and Reagents), Application (Disease Screening and Blood Grouping), and End User (Hospitals, Diagnostic Laboratories, and Plasma Fractionation Companies)
Blood Transfusion Diagnostics Market
Current and future Market Scenario
According to our new market research study on “Blood Transfusion Diagnostics Market to 2028 – Global Analysis and Forecast – by Type, Treatment, and End User,” the market is expected to grow from US$ 4,096.93 million in 2021 to US$ 6,483.75 million by 2028. It is estimated to grow at a CAGR of 6.9% from 2022 to 2028..
The blood transfusion diagnostics is increasing with the rapid rise in number of chronic diseases such as anemia, kidney disorders, etc. Blood transfusion diagnostics are widely used before surgeries in various surgical procedures, such as cardiac surgery and other invasive procedures. Chronic diseases, such as cancer, cardiovascular diseases, and renal disorders, are major causes of human death worldwide. These conditions are generally treated via surgical procedures, which are associated with a chance of excessive blood loss for which fresh blood is transfused into patients to maintain their normal blood levels.
